The global Api Drug Development market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2029.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Api Drug Development market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Almac
Patheon pharma services
Seqens
Malvern Panalytical
CordenPharma
Eurofins CDMO
API Corporation
Wavelength
Sterling
Drug Discovery Alliances
API Pharma tech
Biocon
Segment by Type
Synthetic Type
Natural Type
Segment by Application
Pharmaceutical
Chemical Industry
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Api Drug Development report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Global market size, regional market size. Market Opportunities and Challenges
Chapter 3: Companies’ Competition Patterns
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6 to 10: Country Level Value Analysis
Chapter 11: Companies’ Outline
Chapter 12: Market Conclusions
Chapter 13: Research Methodology and Data Source
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Api Drug Development Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Synthetic Type
1.2.3 Natural Type
1.3 Market by Application
1.3.1 Global Api Drug Development Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Pharmaceutical
1.3.3 Chemical Industry
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Api Drug Development Market Perspective (2018-2029)
2.2 Api Drug Development Growth Trends by Region
2.2.1 Global Api Drug Development Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Api Drug Development Historic Market Size by Region (2018-2023)
2.2.3 Api Drug Development Forecasted Market Size by Region (2024-2029)
2.3 Api Drug Development Market Dynamics
2.3.1 Api Drug Development Industry Trends
2.3.2 Api Drug Development Market Drivers
2.3.3 Api Drug Development Market Challenges
2.3.4 Api Drug Development Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Api Drug Development Players by Revenue
3.1.1 Global Top Api Drug Development Players by Revenue (2018-2023)
3.1.2 Global Api Drug Development Revenue Market Share by Players (2018-2023)
3.2 Global Api Drug Development Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Api Drug Development Revenue
3.4 Global Api Drug Development Market Concentration Ratio
3.4.1 Global Api Drug Development Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Api Drug Development Revenue in 2022
3.5 Api Drug Development Key Players Head office and Area Served
3.6 Key Players Api Drug Development Product Solution and Service
3.7 Date of Enter into Api Drug Development Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Api Drug Development Breakdown Data by Type
4.1 Global Api Drug Development Historic Market Size by Type (2018-2023)
4.2 Global Api Drug Development Forecasted Market Size by Type (2024-2029)
5 Api Drug Development Breakdown Data by Application
5.1 Global Api Drug Development Historic Market Size by Application (2018-2023)
5.2 Global Api Drug Development Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Api Drug Development Market Size (2018-2029)
6.2 North America Api Drug Development Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Api Drug Development Market Size by Country (2018-2023)
6.4 North America Api Drug Development Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Api Drug Development Market Size (2018-2029)
7.2 Europe Api Drug Development Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Api Drug Development Market Size by Country (2018-2023)
7.4 Europe Api Drug Development Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Api Drug Development Market Size (2018-2029)
8.2 Asia-Pacific Api Drug Development Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Api Drug Development Market Size by Region (2018-2023)
8.4 Asia-Pacific Api Drug Development Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Api Drug Development Market Size (2018-2029)
9.2 Latin America Api Drug Development Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Api Drug Development Market Size by Country (2018-2023)
9.4 Latin America Api Drug Development Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Api Drug Development Market Size (2018-2029)
10.2 Middle East & Africa Api Drug Development Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Api Drug Development Market Size by Country (2018-2023)
10.4 Middle East & Africa Api Drug Development Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Almac
11.1.1 Almac Company Detail
11.1.2 Almac Business Overview
11.1.3 Almac Api Drug Development Introduction
11.1.4 Almac Revenue in Api Drug Development Business (2018-2023)
11.1.5 Almac Recent Development
11.2 Patheon pharma services
11.2.1 Patheon pharma services Company Detail
11.2.2 Patheon pharma services Business Overview
11.2.3 Patheon pharma services Api Drug Development Introduction
11.2.4 Patheon pharma services Revenue in Api Drug Development Business (2018-2023)
11.2.5 Patheon pharma services Recent Development
11.3 Seqens
11.3.1 Seqens Company Detail
11.3.2 Seqens Business Overview
11.3.3 Seqens Api Drug Development Introduction
11.3.4 Seqens Revenue in Api Drug Development Business (2018-2023)
11.3.5 Seqens Recent Development
11.4 Malvern Panalytical
11.4.1 Malvern Panalytical Company Detail
11.4.2 Malvern Panalytical Business Overview
11.4.3 Malvern Panalytical Api Drug Development Introduction
11.4.4 Malvern Panalytical Revenue in Api Drug Development Business (2018-2023)
11.4.5 Malvern Panalytical Recent Development
11.5 CordenPharma
11.5.1 CordenPharma Company Detail
11.5.2 CordenPharma Business Overview
11.5.3 CordenPharma Api Drug Development Introduction
11.5.4 CordenPharma Revenue in Api Drug Development Business (2018-2023)
11.5.5 CordenPharma Recent Development
11.6 Eurofins CDMO
11.6.1 Eurofins CDMO Company Detail
11.6.2 Eurofins CDMO Business Overview
11.6.3 Eurofins CDMO Api Drug Development Introduction
11.6.4 Eurofins CDMO Revenue in Api Drug Development Business (2018-2023)
11.6.5 Eurofins CDMO Recent Development
11.7 API Corporation
11.7.1 API Corporation Company Detail
11.7.2 API Corporation Business Overview
11.7.3 API Corporation Api Drug Development Introduction
11.7.4 API Corporation Revenue in Api Drug Development Business (2018-2023)
11.7.5 API Corporation Recent Development
11.8 Wavelength
11.8.1 Wavelength Company Detail
11.8.2 Wavelength Business Overview
11.8.3 Wavelength Api Drug Development Introduction
11.8.4 Wavelength Revenue in Api Drug Development Business (2018-2023)
11.8.5 Wavelength Recent Development
11.9 Sterling
11.9.1 Sterling Company Detail
11.9.2 Sterling Business Overview
11.9.3 Sterling Api Drug Development Introduction
11.9.4 Sterling Revenue in Api Drug Development Business (2018-2023)
11.9.5 Sterling Recent Development
11.10 Drug Discovery Alliances
11.10.1 Drug Discovery Alliances Company Detail
11.10.2 Drug Discovery Alliances Business Overview
11.10.3 Drug Discovery Alliances Api Drug Development Introduction
11.10.4 Drug Discovery Alliances Revenue in Api Drug Development Business (2018-2023)
11.10.5 Drug Discovery Alliances Recent Development
11.11 API Pharma tech
11.11.1 API Pharma tech Company Detail
11.11.2 API Pharma tech Business Overview
11.11.3 API Pharma tech Api Drug Development Introduction
11.11.4 API Pharma tech Revenue in Api Drug Development Business (2018-2023)
11.11.5 API Pharma tech Recent Development
11.12 Biocon
11.12.1 Biocon Company Detail
11.12.2 Biocon Business Overview
11.12.3 Biocon Api Drug Development Introduction
11.12.4 Biocon Revenue in Api Drug Development Business (2018-2023)
11.12.5 Biocon Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Almac
Patheon pharma services
Seqens
Malvern Panalytical
CordenPharma
Eurofins CDMO
API Corporation
Wavelength
Sterling
Drug Discovery Alliances
API Pharma tech
Biocon
Ěý
Ěý
*If Applicable.
